ID: ALA4561393

Max Phase: Preclinical

Molecular Formula: C36H36Cl2F3N7O7S

Molecular Weight: 724.67

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CN(C)C/C=C/C(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]c(-c4ccccc4)c3NC(=O)c3c(Cl)cccc3Cl)CC2)c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C34H35Cl2N7O5S.C2HF3O2/c1-42(2)18-8-15-28(44)37-24-11-6-12-25(21-24)49(47,48)43-19-16-23(17-20-43)38-34(46)32-31(30(40-41-32)22-9-4-3-5-10-22)39-33(45)29-26(35)13-7-14-27(29)36;3-2(4,5)1(6)7/h3-15,21,23H,16-20H2,1-2H3,(H,37,44)(H,38,46)(H,39,45)(H,40,41);(H,6,7)/b15-8+;

Standard InChI Key:  YYQZQBAELRXTSM-TWNLEINFSA-N

Associated Targets(Human)

Cyclin-dependent kinase 14/Cyclin-Y 136 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 724.67Molecular Weight (Monoisotopic): 723.1797AlogP: 5.28#Rotatable Bonds: 11
Polar Surface Area: 156.60Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 8.68CX Basic pKa: 9.05CX LogP: 4.25CX LogD: 3.49
Aromatic Rings: 4Heavy Atoms: 49QED Weighted: 0.15Np Likeness Score: -1.52

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source